Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in Maitland. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in Maitland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
The purpose of this clinical study is to determine the efficacy and safety of a new oral cladribine formulation in participants with Generalized Myasthenia Gravis (gMG) in comparison to placebo. It will also investigate the sustained efficacy, the need for retreatment, and the long-term safety of oral cladribine in gMG. An additional component is included to characterize the Pharmacokinetics (PK) of the new cladribine formulation in gMG participants. This study is divided into 3 periods: the dou
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Check if you qualify for this myasthenia gravis clinical trial in Maitland, FL
If you're searching for myasthenia gravis treatment options in Maitland, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Maitland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.